February 17, 2022

CDC Draft Clinical Practice Guideline for Prescribing Opioids

The CDC draft Clinical Practice Guideline for Prescribing Opioids (update to the 2016 Guideline for Prescribing Opioids for Chronic Pain) has posted in the Federal Register and the 60-day public comment period is now open. Members of the public can provide comment by visiting the Federal Register. Please note that the 60-day public comment period will end on April 11, 2022.

Live Patient Safety Continuing Education Webinar Hosted by FDA’s Division of Drug Information for Students and Health Care Professionals

The National Association of Boards of Pharmacy (NABP) is pleased to announce that the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Division of Drug Information is presenting a series of live continuing education (CE) webinars designed to aid health care professionals and future clinicians to provide better patient care by knowing how to find relevant FDA regulatory information that will improve drug safety. The webinars are presented by FDA staff.

FDA Drug Topics: Counseling Patients on Generic Drugs
Date: Tuesday, February 22, 2022
Time: 1 PM EDT | 10 AM PDT
Duration: 60 minutes

This webinar will equip health care providers with information and knowledge on how to answer questions that patients may have about generic drugs, such as whether generic drugs work the same as brand-name drugs, why they might look different, why they cost less, and if they are as safe as the brand-name drug. The webinar will also supply health care providers with information on therapeutic equivalence and how they can locate a generic drug equivalent for their patients.

After signing up for this webinar, registrants will receive a calendar invitation with details on how to join the online meeting. Instructions on how to claim CE credit and obtain a copy of the presentation slides will be emailed to participants the next business day after the webinar.

Please note that the webinar capacity is 1,500 participants; registration does not guarantee entry. Those who are unable to join the meeting may either view the webinar recording that will be posted online or participate in the home study CE course that will be available in a few weeks.

The FDA CDER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

NABP encourages you to forward this information to your staff and to health care professionals in your state. For more information and to learn about future webinars, please visit www.fda.gov/DDIWebinars.